Metformin Oresund Pharma Aps (Metformin Hydrochloride)

Metformin activates AMP‑activated protein kinase (AMPK) and inhibits mitochondrial complex I, which together suppress hepatic gluconeogenesis. It also enhances peripheral insulin sensitivity, allowing muscle and fat cells to take up glucose more efficiently, resulting in lower blood sugar levels.

The appropriate dose of Metformin Oresund Pharma Aps is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Metformin during pregnancy or lactation should be evaluated by a qualified clinician. While some guidelines allow its use when benefits outweigh risks, the decision must be individualized, and patients should discuss potential effects with their obstetric or pediatric provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is often preferred as first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycaemia when used alone. Compared with sulfonylureas or insulin, it has a different mechanism—targeting hepatic glucose output—and is generally well tolerated.

Metformin Oresund Pharma Aps should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat and direct sunlight, and discard any product that appears discoloured or damaged.

Metformin Oresund Pharma Aps is taken orally, usually with meals to minimise gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain or unusual fatigue develop.

Metformin is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those receiving iodinated contrast studies without appropriate renal monitoring.